Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Joshua Meeks

12PUBLICATIONS

90CO-AUTHORS

Innate immunityPredictive and prognostic markersNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jan 02, 2026

STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance.

Joseph R Podojil, Andrew C Cogswell, Tobias Neef

|Sep 10, 2025

Low-grade non-muscle-invasive bladder cancer: molecular landscape, treatment strategies and emerging therapies.

Lexiaochuan Wen, Hiroko Miyagi, Philippe E Spiess

|Dec 03, 2024

Nectin-4 Positivity in Genitourinary Malignancies: A Systematic Review.

Emanuele Crupi, Tiago Costa de Padua, Laura Marandino

|Jul 02, 2024

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Roger Li, Paras H Shah, Tyler F Stewart

|Jun 18, 2024

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Roger Li, Paras H Shah, Tyler F Stewart

|Jun 06, 2024

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial.

Roger Li, Paras H Shah, Tyler F Stewart

Pageof 2

Frequent Collaborators

5 joint publications

Ashish M Kamat

4 joint publications

Roger Li

2 joint publications

Philippe E Spiess

2 joint publications

Joseph R Podojil

2 joint publications

Stephen D Miller

2 joint publications

Seth P Lerner

1 joint publications

A Gordon Robertson

1 joint publications

Markus Eckstein

1 joint publications

Lu Wang

1 joint publications

Ali Shilatifard

Frequent Collaborators

5 joint publications

Ashish M Kamat

4 joint publications

Roger Li

2 joint publications

Philippe E Spiess

2 joint publications

Joseph R Podojil

Top Related Videos

Assessing the Innate Sensing of HIV-1 Infected CD4<sup>+</sup> T Cells by Plasmacytoid Dendritic Cells Using an <em>Ex vivo</em> Co-culture System.

Assessing the Innate Sensing of HIV-1 Infected CD4<sup>+</sup> T Cells by Plasmacytoid Dendritic Cells Using an <em>Ex vivo</em> Co-culture System.

Published on : Sep 01, 2015

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on : Sep 16, 2019

See more related videos

Top Related Videos

Assessing the Innate Sensing of HIV-1 Infected CD4<sup>+</sup> T Cells by Plasmacytoid Dendritic Cells Using an <em>Ex vivo</em> Co-culture System.

Assessing the Innate Sensing of HIV-1 Infected CD4<sup>+</sup> T Cells by Plasmacytoid Dendritic Cells Using an <em>Ex vivo</em> Co-culture System.

Published on : Sep 01, 2015

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on : Sep 16, 2019

See more related videos